Search
Now showing items 1-10 of 16
Development of a pharmaceutical care program in progressive stages in geriatric institutions
(BioMed Central, 2018-12)
Background: To introduce and manage a Pharmaceutical care programs in geriatric care institutions presents difficulties such as reduced pharmacy service staff, complexity of the patients or lack of ...
Pharmacogenetics of antipsychotics: clinical utility and implementationPharmacogenetics of antipsychotics: clinical utility and implementation
(Elsevier, 2020-12)
Decades of research have produced extensive evidence of the contribution of genetic factors to
the efficacy and toxicity of antipsychotics. Numerous genetic variants in genes controlling drug
availability ...
Pharmacist intervention program at different rent levels of geriatric healthcare
(MDPI, 2017-05)
As a pharmacy service giving pharmaceutical care at different levels of health care for elderly people, we needed a standardization procedure for recording and evaluating pharmacists’ interventions. Our ...
Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis
(MDPI, 2023-03)
We conducted a systematic review and meta-analysis to gain insight into the characteristics and clinical impact of electronic monitoring devices of inhalers (EMDs) and their clinical interventions in ...
Programa de coordinación en la transición asistencial para la mejora de la farmacoterapia entre un Servicio de Urgencias y un Centro Sociosanitario
(Organización de Farmacéuticos Ibero-Latinoamericanos (OFIL), 2022)
Objetivos: Describir un programa de colaboración entre farmacéuticos de un Servicio de Urgencias y un Centro sociosanitario, así como evaluar su impacto sobre la frecuencia de reconsulta al Servicio de ...
CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders
(Dove Medical Press, 2022-11)
Purpose
Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...
Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders
(OAE Publishing, 2021-07)
Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ...
Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers
(MDPI, 2022-05)
BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ...
The Impact of pharmaceutical care in multidisciplinary teams on health outcomes: systematic review and meta-analysis
(Elsevier, 2021-07)
Objectives
Pharmacists’ care has an essential role in multidisciplinary teams in charge of chronic patients. However, data available on the clinical outcomes of these activities appear inconclusive. ...
Adverse drug events in patients with dementia and neuropsychiatric/behavioral, and psychological symptoms, a one-year prospective study
(MDPI, 2019-03)
Older people usually present with adverse drug events (ADEs) with nonspecific symptoms such as cognitive decline, recurrent falls, reduced mobility, and/or major deterioration. The aims of this study ...